In April 2020, we raised $78,054 in donations and pledges from 2,512 supporters. Of that amount, $76,634 was for general support, $389 was for the Zendo Project, $780 was for MDMA related projects and $250 for ibogaine research. Additional funds were raised for fiscal sponsorships ($35,002).
The positive outcome of the interim analysis in March 2020 indicates that with sufficient funding, we have an excellent chance of generating additional promising safety and efficacy data and potentially receiving FDA approval for MDMA-assisted psychotherapy for PTSD by the end of 2022.
We are particularly grateful to the following supporters for their generous contributions of $1000 or more.
Anonymous – $10,256
Andrej Cvoro – $1,726
Leonard and Vivian Lehmann – $1,000
MUD\WTR – $1,000
Christian Saenger – $1,000
Jiri Techet – $1,000
Anonymous – $1,000
Auryn Fund, Donor Advised Fund via Schwab Charitable – $25,000 (Auyrn Project)
Anonymous – $7,000 (Auryn Project)
Ryan Zurrer – $1,500 (Auryn Project)
Salesforce – $1,000 (Psychedelic Seminars)
MAPS relies on the generosity of individual donors to achieve its mission. Psychedelic science is again being conducted under federal guidelines, but no funding for psychedelic psychotherapy research is yet available from governments or major foundations.